US$ 374.58
bei vorhandener Technologie
3Problem der Unsicherheit12
technology push
3ROLLENZUSCHREIBUNGEN10
The New Drug Reimbursement Game Rutilius Taurus Aemilianus bei vorhandener TechnologieThis comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss for the populations future health due to less innovation. It starts with a critical review of the empirical evidence of the return to consumers on their ongoing investment into high drug prices in order to increase future innovation. The implicit, critical
US$ 374.58
US$ 393.31
US$ 547.05
US$ 278.97
US$ 278.97
US$ 207.53
US$ 547.05
US$ 547.05
US$ 278.97
US$ 287.35
US$ 560.74
US$ 432.65